Connect with us

Business

‘Historic moment’: US regulators approve landmark Alzheimer’s drug – Sydney Morning Herald

The US Food and Drug Administration’s controversial decision delighted advocacy groups but defied the wishes of many top experts…

Published

on

Article feature image

Washington: US regulators have approved the first ever medication for Alzheimers disease aimed at slowing cognitive decline, a controversial decision that delighted advocacy groups but defied the wishes of many top experts in the field.
The Food and Drug…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending